BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 17386117)

  • 1. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P; Zinser JW; Correa-Rotter R
    BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
    N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
    Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
    Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib-induced regression of AIDS-related Kaposi's sarcoma.
    Koon HB; Bubley GJ; Pantanowitz L; Masiello D; Smith B; Crosby K; Proper J; Weeden W; Miller TE; Chatis P; Egorin MJ; Tahan SR; Dezube BJ
    J Clin Oncol; 2005 Feb; 23(5):982-9. PubMed ID: 15572730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
    Campione E; Diluvio L; Paternò EJ; Di Marcantonio D; Francesconi A; Terrinoni A; Orlandi A; Chimenti S
    Clin Ther; 2009 Nov; 31(11):2565-9. PubMed ID: 20110001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient.
    Gheith O; Bakr A; Wafa E; Fouda A; El Agroudy A; Refaie A; Donia A; Sabry A; Sobh M; Shokeir A; Ghoneim M
    Clin Exp Nephrol; 2007 Sep; 11(3):251-254. PubMed ID: 17891357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of post-transplant Kaposi's sarcoma using sirolimus.
    Kolhe N; Mamode N; Van der Walt J; Pattison J
    Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of post-renal transplant gastric and pulmonary Kaposi's sarcoma with conversion to rapamycin treatment.
    Charfi S; Krichen-Makni S; Yaich S; Makni H; Khabir A; Amouri A; Charfeddine K; Hachicha J; Sellami-Boudawara T
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):617-20. PubMed ID: 17951954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
    Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
    Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual Kaposi's sarcoma in a renal transplant recipient.
    Costa Ferreira P; Miguel Pereira J; Oliveira I; Pinho C; Cardoso A; Reis J; Amarante J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2830-1. PubMed ID: 16204279
    [No Abstract]   [Full Text] [Related]  

  • 11. Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris.
    Saggar S; Zeichner JA; Brown TT; Phelps RG; Cohen SR
    Arch Dermatol; 2008 May; 144(5):654-7. PubMed ID: 18490593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of Kaposi's sarcoma in a Sudanese kidney transplant recipient after conversion to sirolimus: a focus on a common clinical problem.
    Yousif ME; El Hassan AM
    Arab J Nephrol Transplant; 2011 Jan; 4(1):49-52. PubMed ID: 21469595
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of an Early Kaposi's Sarcoma Case Post Kidney Transplantation by Sirolimus: A Case Report.
    Najafi F; Kafaie P; Neamatzadeh H
    Acta Med Iran; 2017 Feb; 55(2):139-141. PubMed ID: 28282713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
    Campistol JM; Schena FP
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression.
    Stallone G; Infante B; Grandaliano G; Schena FP; Gesualdo L
    Transpl Int; 2008 Sep; 21(9):825-32. PubMed ID: 18498314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France.
    Farge D
    Eur J Med; 1993; 2(6):339-43. PubMed ID: 8252179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertebral Lesions from AIDS-Related Kaposi's Sarcoma.
    Di Bella S; Capone A; Olearo F; Johnson E; Chinello P; Baiocchini A; Del Nonno F; Busi Rizzi E; Petrosillo N
    Curr HIV Res; 2011 Jun; 9(4):270-5. PubMed ID: 21631426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Hodgkin's disease and Kaposi sarcoma in a renal transplant recipient.
    Yaich S; Zagdane S; Charfeddine K; Hssairi D; Hachicha J
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):306-9. PubMed ID: 20228518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient.
    Basu G; Mohapatra A; Manipadam MT; Mani SE; John GT
    Nephrol Dial Transplant; 2011 Oct; 26(10):3412-5. PubMed ID: 21775763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment.
    Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M
    Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.